Patents by Inventor Nicholas Kindon

Nicholas Kindon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6162808
    Abstract: The invention relates to new pharmaceutically active compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.
    Type: Grant
    Filed: June 10, 1998
    Date of Patent: December 19, 2000
    Assignee: AstraZeneca U.K. Limited
    Inventors: Nicholas Kindon, Premji Meghani, Stephen Thom
  • Patent number: 6107297
    Abstract: The invention relates to new pharmaceutically active compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.
    Type: Grant
    Filed: September 30, 1998
    Date of Patent: August 22, 2000
    Assignee: Astra Pharmaceuticals Limited
    Inventors: Nicholas Kindon, Premji Meghani, Stephen Thom
  • Patent number: 5985849
    Abstract: A compound of the formula (I) or salts thereof: ##STR1## wherein X, R.sup.1, Q.sup.1 and Q.sup.2 are as defined in the specification. The compounds have been found to be P2 7-TM G-protein receptor antagonists, especially to the P2 Y2 receptor, and are useful in therapy, for example as anti-inflammatory agents useful in the treatment of a number of inflammatory diseases such as asthma, inflammatory bowel disease, ARDS, psoriasis, rheumatoid arthritis, myocardial ischaemia, COPD, cystic fibrosis, arthrosclerosis, restenosis, peridontal disease, septic shock, osteoarthritis and stroke.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: November 16, 1999
    Assignee: Astra Pharmaceuticals Ltd.
    Inventors: Nicholas Kindon, Premji Meghani, Stephen Thom